Associations among serum FGF21 levels, inflammation, and metabolic dysfunction-associated steatotic liver disease: mediation analyses in a Chinese community-based population
Objective: This study aimed to explore the relationship between serum fibroblast growth factor 21 (FGF21) levels and metabolic dysfunction-associated steatotic liver disease (MASLD), and further explore the mediation effect of inflammation in their association. Methods: This study included 1,710 com...
Saved in:
| Main Authors: | Hongyu Tan, Tingting Hu, Yunhui Pan, Yiting Xu, Yufei Wang, Xiaojing Ma, Yuqian Bao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-08-01
|
| Series: | Endocrine Connections |
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/14/8/EC-25-0351.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction‐associated steatotic liver disease
by: Shifang Tang, et al.
Published: (2025-02-01) -
Analytical and Clinical Validation of a Plasma Fibroblast Growth Factor 21 ELISA Kit Using an Automated Platform in Steatotic Liver Disease
by: Makito Tanaka, et al.
Published: (2025-06-01) -
Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
by: Tugce Ozlu Karahan, et al.
Published: (2025-04-01) -
Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease
by: Jong Wook Choi, et al.
Published: (2024-11-01) -
Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01)